A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy

NCT03015623 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Kidney Injury

Interventions

BIOLOGICAL: SBI-101
DEVICE: Sham

Sponsor

Sentien Biotechnologies, Inc.